ES2105939B1 - Nuevos pirazoles con actividad antagonista de la angiotensina ii. - Google Patents
Nuevos pirazoles con actividad antagonista de la angiotensina ii.Info
- Publication number
- ES2105939B1 ES2105939B1 ES09401711A ES9401711A ES2105939B1 ES 2105939 B1 ES2105939 B1 ES 2105939B1 ES 09401711 A ES09401711 A ES 09401711A ES 9401711 A ES9401711 A ES 9401711A ES 2105939 B1 ES2105939 B1 ES 2105939B1
- Authority
- ES
- Spain
- Prior art keywords
- alkyl
- angiotensin
- aryl
- pirazoles
- new
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Chemical Or Physical Treatment Of Fibers (AREA)
Abstract
COMPUESTOS DE FORMULA I Y SUS SALES Y SOLVATOS, EN DONDE R1 SIGNIFICA HIDROGENO, C1-6 ALQUILO, C1-6 HALOALQUILO, ARILO, -(CH2)MR5, O -(CH2)MCOR6; R2 REPRESENTA C1-6 HIDROXIALQUILO, C3-7 CICLOALQUILO, C3-7 CICLOALQUIL, C1-4 ALQUILO O ARILO; R3 REPRESENTA -(CH2)NR7 O -(CH2)NCOR7_; R4 REPRESENTA ENTRE OTROS -CO2H O -TETRAZOL-5-IL; R5 REPRESENTA HIDROXI, C1-6 ALQUILO, C1-6 ALCOXI, ARILO, ARILOXI O UN GRUPO NR10R11; R7 REPRESENTA HIDROGENO, HIDROXI, C1-6 ALCOXI, ARILOXI O ARILC1-4 ALCOXI; R10 Y R11 REPRESENTAN INDEPENDIENTEMENTE HIDROGENO O C1-6 ALQUILO; M REPRESENTA 1, 2, 3, O 4; N REPRESENTA 1, 2 O 3; Y P REPRESENTA 0, 1 O 2. DICHOS COMPUESTOS SON UTILES COMO ANTAGONISTAS DE LA ANGIOTENSINA II. LA PRESENTE INVENCION DESCRIBE TAMBIEN PROCEDIMIENTOS PARA SU OBTENCION Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN.
Priority Applications (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES09401711A ES2105939B1 (es) | 1994-08-02 | 1994-08-02 | Nuevos pirazoles con actividad antagonista de la angiotensina ii. |
| PCT/EP1995/003086 WO1996004273A1 (en) | 1994-08-02 | 1995-08-02 | New pyrazole derivatives as angiotensin ii antagonist |
| CA002173258A CA2173258A1 (en) | 1994-08-02 | 1995-08-02 | New pyrazole derivatives as angiotensin ii antagonist |
| JP8506213A JPH09504804A (ja) | 1994-08-02 | 1995-08-02 | アンジオテンシンii拮抗薬としての新規なピラゾール誘導体 |
| EP95929067A EP0721454A1 (en) | 1994-08-02 | 1995-08-02 | New pyrazole derivatives as angiotensin ii antagonist |
| AU32563/95A AU3256395A (en) | 1994-08-02 | 1995-08-02 | New pyrazole derivatives as angiotensin ii antagonist |
| US08/624,459 US5827863A (en) | 1994-08-02 | 1995-08-02 | Pyrazole derivatives as angiotensin II antagonists |
| NO961333A NO961333D0 (no) | 1994-08-02 | 1996-04-01 | Nye pyrazolderivater som angiotensin-II-antagonister |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES09401711A ES2105939B1 (es) | 1994-08-02 | 1994-08-02 | Nuevos pirazoles con actividad antagonista de la angiotensina ii. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2105939A1 ES2105939A1 (es) | 1997-10-16 |
| ES2105939B1 true ES2105939B1 (es) | 1998-07-01 |
Family
ID=8287143
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES09401711A Expired - Lifetime ES2105939B1 (es) | 1994-08-02 | 1994-08-02 | Nuevos pirazoles con actividad antagonista de la angiotensina ii. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5827863A (es) |
| EP (1) | EP0721454A1 (es) |
| JP (1) | JPH09504804A (es) |
| AU (1) | AU3256395A (es) |
| CA (1) | CA2173258A1 (es) |
| ES (1) | ES2105939B1 (es) |
| NO (1) | NO961333D0 (es) |
| WO (1) | WO1996004273A1 (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4432860A1 (de) * | 1994-09-15 | 1996-03-21 | Merck Patent Gmbh | Imidazopyridine |
| DE19645313A1 (de) | 1996-11-04 | 1998-05-07 | Basf Ag | Substituierte 3-Benzylpyrazole |
| SE9903028D0 (sv) * | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
| SK2692002A3 (en) * | 1999-08-30 | 2002-07-02 | Aventis Pharma Gmbh | Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events |
| HU222773B1 (hu) * | 2000-04-21 | 2003-10-28 | Richter Gedeon Vegyészeti Gyár Rt. | Eljárás egy ismert tetrazolszármazék előállítására |
| DE10105916A1 (de) * | 2001-02-09 | 2002-08-22 | Siemens Ag | Amorphe organische 1,3,2-Dioxaborinluminophore, Verfahren zu deren Herstellung und Verwendung davon |
| US7107198B2 (en) * | 2001-11-02 | 2006-09-12 | Sun Microsystems, Inc. | Automatic generation of reduced-size circuit models including inductive interaction |
| EP2128138A1 (en) | 2007-01-29 | 2009-12-02 | Takeda Pharmaceutical Company Limited | Pyrazole compound |
| WO2011005674A1 (en) * | 2009-07-07 | 2011-01-13 | Theravance, Inc. | Dual-acting pyrazole antihypertensive agents |
| CN103772282B (zh) * | 2014-02-26 | 2015-09-23 | 上海毕得医药科技有限公司 | 一种3-叔丁基-1h-吡唑-4-甲醛的制备方法 |
| WO2016035328A1 (ja) | 2014-09-01 | 2016-03-10 | キヤノン株式会社 | 化合物、分散剤及びトナー |
| PY2485940A (es) * | 2023-10-06 | 2025-10-30 | Sumitomo Chemical Company Ltd | Compuestos de biarilo y método para controlar enfermedades vegetales |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5189048A (en) * | 1988-01-07 | 1993-02-23 | E. I. Du Pont De Nemours And Company | Substituted 1,2,3 triazole angiotensin II antagonists |
| GB9005354D0 (en) * | 1990-03-09 | 1990-05-02 | Glaxo Group Ltd | Chemical compounds |
| WO1993005025A1 (en) * | 1991-09-06 | 1993-03-18 | Glaxo Group Limited | C-linked pyrazole derivatives |
| AT398202B (de) * | 1991-10-04 | 1994-10-25 | Chem Pharm Forsch Gmbh | Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung |
-
1994
- 1994-08-02 ES ES09401711A patent/ES2105939B1/es not_active Expired - Lifetime
-
1995
- 1995-08-02 EP EP95929067A patent/EP0721454A1/en not_active Ceased
- 1995-08-02 WO PCT/EP1995/003086 patent/WO1996004273A1/en not_active Ceased
- 1995-08-02 US US08/624,459 patent/US5827863A/en not_active Expired - Fee Related
- 1995-08-02 CA CA002173258A patent/CA2173258A1/en not_active Abandoned
- 1995-08-02 JP JP8506213A patent/JPH09504804A/ja active Pending
- 1995-08-02 AU AU32563/95A patent/AU3256395A/en not_active Abandoned
-
1996
- 1996-04-01 NO NO961333A patent/NO961333D0/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0721454A1 (en) | 1996-07-17 |
| NO961333L (no) | 1996-04-01 |
| ES2105939A1 (es) | 1997-10-16 |
| NO961333D0 (no) | 1996-04-01 |
| CA2173258A1 (en) | 1996-02-15 |
| JPH09504804A (ja) | 1997-05-13 |
| AU3256395A (en) | 1996-03-04 |
| WO1996004273A1 (en) | 1996-02-15 |
| US5827863A (en) | 1998-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8105694A1 (es) | Procedimiento para la produccion de propenilaminas | |
| ES2100907T3 (es) | Bencimidazoles, medicamentos que contienen estos compuestos y proced imiento para su preparacion. | |
| ES2105939B1 (es) | Nuevos pirazoles con actividad antagonista de la angiotensina ii. | |
| ECSP045229A (es) | Piridinonas sustituidas como moduladores de la p38 map quinasa | |
| AR026826A1 (es) | Arilcetonas sustituidas | |
| AR240929A2 (es) | "n-piridinsulfonil-n'-piridinil-y-triazinil-ureas procedimiento parasu preparacion, intermediarios para uso exclusivo en dicho procedimiento, y composiciones que contienen dichas ureas" | |
| CO4920223A1 (es) | Derivados de 1,3,8-triaza-espiro[4,5]decan-4-ona 8- sustituidos | |
| ES2118095T3 (es) | Bencimidazoles, medicamentos que contienen estos compuestos y procedimiento para su preparacion. | |
| ES2074219T3 (es) | 1,4,7,10-tetraazaciclododecano-butiltrioles, procedimiento para su preparacion y agentes farmaceuticos que los contienen. | |
| ES2033840T3 (es) | P-aminoetilsulfonanilidas n-sustituidas como agentes antiarritmicos; e intermedios para los mismos. | |
| AR077414A2 (es) | Compuestos de piperazina como antagonistas de taquinina sus sales y solvatos composiciones farmaceuticas que lo contienen su uso y procesos para su preparacion | |
| MX9605128A (es) | Nuevos derivados de aminoacidos, procedimientos para su preparacion y composiciones farmaceuticas que contienen estos compuestos. | |
| ES8405364A1 (es) | Metodo de preparar amidoaminoacidos n-substituidos. | |
| AR003937A1 (es) | Compuesto ciclico que tiene efecto antagonico al receptor de taquiquinina, proceso para producirlo y composicion farmaceutica que lo contiene. | |
| CR6805A (es) | Derivados novedosos de eter de propargil-fenil | |
| AR006720A1 (es) | Un compuesto derivado de azahexano heterociclico, su uso para la preparacion de una composicion farmaceutica, procedimiento para prepararlo y una composicion farmaceutica que lo comprende | |
| ES2150039T3 (es) | Benzonitrilos como 5-ht agonistas y antagonistas. | |
| UY26513A1 (es) | Nuevas piperidinas sustituidas, medicamentos que contienen estos compuestos y procedimiento para su preparación. | |
| AR007969A1 (es) | Compuestos derivados de pirroles sustituidos, su utilizacion y composiciones farmaceuticas que contienen tales compuestos | |
| UY28848A1 (es) | Antagonistas de cgrp seleccionados, procedimientos para su preparación, y su empleo como medicamentos | |
| ES2052539T3 (es) | Procedimiento para preparar isoxazolidinas 2,3-disustituidas. | |
| ES8305695A1 (es) | Procedimiento para preparar derivados de amidas. | |
| ES2054062T3 (es) | N-cicloalquilalquilo benzilaminas alfa, alfa y substituidos, su procedimiento de preparacion, su utilizacion como medicamento y sus intermedios de sintesis. | |
| ES2197003B1 (es) | Nuevos compuestos antagonistas de integrinas alfa. | |
| ES2106936T3 (es) | Derivados de carbazolona y procedimientos para su preparacion. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EC2A | Search report published |
Date of ref document: 19971016 Kind code of ref document: A1 Effective date: 19971016 |